Exploring iDose® TR: The Future of Glaucoma Management thumbnail

Exploring iDose® TR: The Future of Glaucoma Management

Published Dec 04, 24
1 min read


iDose® TR is a game-changing innovation in the treatment of glaucoma, offering a sustained and effective solution for managing intraocular pressure (IOP). In contrast to traditional eye drops that need to be applied every day, iDose® TR is a compact, implantable device engineered to release a controlled release of medication directly into the eye over an extended period. This cutting-edge approach reduces the burden of constant dosing, significantly improving patient adherence and overall treatment effectiveness.

At Eye Center South, we are proud to offer iDose® TR as part of our comprehensive glaucoma care. The device is implanted during a simple and low-risk procedure, focused on your comfort and ease. Once in place, it ensures a steady dose of the prescribed medication, working to stabilize intraocular pressure and safeguarding your eyesight. Patients who find challenges in the challenges of daily eye drop regimens can find relief from this state-of-the-art treatment.



Visit for more info At Eye Center South